无基质三维培养支持人卵泡从单层到窦腔期发育并获形态正常MII卵母细胞
该研究将19例育龄女性卵巢组织在无基质系统中培养3周,分离次级卵泡后行个体或群体培养6周,并在次级至早期窦腔期添加AMH、随后中和AMH。群体培养中该调控促进卵泡协调生长与功能,IVM后获得形态和超微结构典型的MII卵母细胞。
要点
- 无基质三维培养可支持人卵泡从单层到窦腔期体外发育。
- 阶段特异性AMH调控在群体培养中促进卵泡生长与功能。
- 体外发育卵泡所得卵母细胞经IVM可达MII并具典型形态。
核心结论
- 在FSH存在下,次级至早期窦腔期补充AMH随后去除AMH,可促进群体培养中人卵泡的协调生长与功能,并获得成熟卵母细胞。
研究设计与样本
- 研究纳入19例育龄(22-47岁、有月经周期)因临床原因行卵巢切除或子宫切除患者的卵巢组织样本。
- 卵巢皮质组织块在无基质系统中培养3周,随后分离卵泡进行6周的个体或群体培养。
主要发现
- 卵巢组织培养3周后卵泡长至次级阶段,体外发育卵泡表达AMH且培养液中分泌AMH水平随时间升高(P < 0.05)。
- 分离的次级卵泡在6周个体培养中存活并长至窦腔期,培养液可检测到颗粒细胞和卵泡膜细胞来源的类固醇激素及旁分泌因子。
- AMH调控未改变卵泡存活或卵母细胞成熟,但AMH调控组卵泡直径及类固醇激素和旁分泌因子产生较对照组增加(P < 0.05)。
- 群体培养中分离的次级卵泡形成聚集体并在6周内长至窦腔期,AMH调控组卵母细胞经IVM进展至MII,含正常大小第一极体和减数分裂纺锤体,超微结构典型。
关键数值与推荐
- 卵巢组织培养3周后卵泡达次级阶段,培养液中分泌AMH水平随时间升高(P < 0.05)。
- 个体培养6周后次级卵泡存活并达窦腔期,培养液可检测到类固醇激素和旁分泌因子。
- AMH调控组卵泡直径及类固醇激素和旁分泌因子产生较对照组增加(P < 0.05)。
- 群体培养6周后卵泡聚集体达窦腔期,AMH调控组卵母细胞经IVM达MII并具正常大小第一极体和减数分裂纺锤体。
临床怎么用
- 阶段特异性AMH调控联合无基质群体培养可作为人卵泡体外成熟和生育力保存的潜在策略。
- 体外发育卵泡产生的卵母细胞经IVM可获得形态和超微结构典型的MII卵母细胞。
局限性
- 卵泡来自成年患者新鲜卵巢组织。
- 卵母细胞成熟率相对较低,且卵母细胞仅通过形态学评估。
- 群体培养缺乏对照组,AMH调控的益处尚未确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can group culture with stage-specific anti-Müllerian hormone (AMH) modulation support human follicular development and oocyte maturation in vitro? SUMMARY ANSWER: In the presence of FSH, AMH supplementation at the secondary-to-early antral stage followed by AMH depletion promotes the coordinated growth and function of human follicles during group culture, thereby yielding mature oocytes. WHAT IS KNOWN ALREADY: Stage-specific AMH modulation promotes in-vitro development of nonhuman primate follicles. The group culture method supports nonhuman primate follicle growth from the primary to antral stage, producing developmentally competent oocytes. STUDY DESIGN, SIZE, DURATION: Ovarian tissue samples were collected from 19 patients of reproductive age (22-47 years old having menstrual cycles) who underwent oophorectomy or hysterectomy for clinical purposes. Tissue pieces were cultured in a matrix-free system for 3 weeks followed by isolation of follicles for the subsequent 6-week individual or group culture. PARTICIPANTS/MATERIALS, SETTING, METHODS: Pieces of ovarian cortical tissue were cultured to support primordial follicle activation and early-stage follicle growth. Secondary follicles isolated from cultured tissue were then randomly assigned to two groups for individual culture: control and AMH modulation, i.e., recombinant human AMH protein supplementation during the secondary-to-early antral stage followed by the addition of neutralizing anti-human AMH antibody. Secondary follicles were also cultured in groups with the same AMH modulation. Follicle survival, growth, steroid hormone and paracrine factor production, steroidogenic protein expression, as well as oocyte maturation and morphology were assessed. MAIN RESULTS AND THE ROLE OF CHANCE: Follicles grew to the secondary stage during 3 weeks of ovarian tissue culture. In-vitro-developed follicles expressed AMH and levels of secreted AMH increased (P < 0.05) in the culture media over time. Secondary follicles isolated from cultured ovarian tissue survived and grew to the antral stage during 6 weeks of individual follicle culture. In-vitro-developed antral follicles produced granulosa and theca cell-derived steroid hormones and paracrine factors, which were detectable in the culture media. Germinal vesicle oocytes obtained from cultured follicles exhibited a perinucleolar chromatin rim configuration. AMH modulation did not alter follicle survival or oocyte maturation relative to those of the control follicles. However, follicle diameters, as well as steroid hormone and paracrine factor production, increased (P < 0.05) in the AMH-modulation group compared with the control group. Secondary follicles isolated from cultured ovarian tissue formed aggregates and grew to the antral stage during 6 weeks of group culture. In-vitro-developed antral follicles expressed steroidogenic enzymes and secreted steroid hormones were detectable in the culture media. Oocytes obtained from cultured follicle aggregates with AMH-modulation progressed to the metaphase II stage after IVM, containing a normal-sized first polar body and meiotic spindle. Oocytes exhibited a typical ultrastructure. LIMITATIONS, REASONS FOR CAUTION: Follicles were obtained from fresh ovarian tissue of adult patients. Oocyte maturation rates were relatively low and oocytes were assessed by morphological evaluation. Owing to the lack of a control group, the beneficial effects of AMH modulation remained undetermined for the group culture in this study. WIDER IMPLICATIONS OF THE FINDINGS: Stage-specific AMH modulation supports human follicular development in the matrix-free group culture, which is consistent with previously reported AMH actions on growing follicles in nonhuman primates. Oocytes generated by in-vitro-developed follicles achieve meiotic maturation with a typical morphology and ultrastructure, which supports in-vitro follicle maturation as a potential approach for fertility preservation in women. STUDY FUNDING/COMPETING INTEREST(S): NICHD R01HD082208 and NIH Office of the Director P51OD011092. The authors have no competing interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Xu F, Lawson MS, Bean Y, et al. Matrix-free 3D culture supports human follicular development from the unilaminar to the antral stage in vitro yielding morphologically normal metaphase II oocytes. Hum Reprod. 2021. PMID: 33681988. doi:10.1093/humrep/deab003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。